Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% (Encube Ethicals) Compared to Elimite™ Cream (Permethrin) 5% (Prestium Pharma, Inc.) in the Treatment of Scabies
Conditions
Interventions
Permethrin Cream, 5%
Elimite™ Cream (permethrin) 5%
Locations
15
United States
Applied Research Center of Arkansas
Little Rock, Arkansas, United States
St. Josephs Clinical Research
Anaheim, California, United States
Long Beach Clinical Trials
Long Beach, California, United States
Havana Research Institute
Pasadena, California, United States
Integrity Clinical Research Center, Inc.
Hialeah, Florida, United States
The Chappel Group Research
Kissimmee, Florida, United States
Start Date
June 1, 2017
Primary Completion Date
November 11, 2017
Completion Date
November 11, 2017
Last Updated
March 26, 2019
NCT07305961
NCT06896929
NCT02841215
NCT05819983
NCT05271968
NCT05198947
Lead Sponsor
Encube Ethicals Pvt. Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions